摘要:
The invention relates to novel 11β long-chain substituted estratrienes of general formula (I), wherein R11 is a long-chain residue with one nitrogen and optionally one sulfur atom, that can additionally be terminally functionalized with a perfluoroalkyl group or an optionally substituted aryl group. The inventive compounds are characterized by antiestrogenic or tissue-selective estrogenic properties and are useful in the production of medicaments.
摘要:
New triphenyl ethylenes have the general formula (I), in which n is an integer from 1 to 10, R' is a sulphur-containing organic rest, R'' is a hydrogen atom, an iodine atom or a hydroxyl group, E is a hydrogen atom, G is a hydrogen atom, or E and G form together a methylene bridge. These new compounds have strong anti-oestrogenic properties and are suitable for producing medicaments, for example for treating mammary carcinoma.
摘要:
Described are Ξ-fluorosulphonimides of the general formula (I) (R1-SO2)2NF in which each R1 is a methyl group or the R1 groups together form a -(CH¿2?)n- group in which n=1, 2 or 3, in particular N-fluoromethansulphonimide, (CH3SO2)2NF, their preparation and their use in the electrophilic fluorination of activated C-H bonds in organic molecules.
摘要:
The invention relates to novel 18-methyl-19-nor-17-pregn-4-en-21,17-carbolactones of general formula (I), where Z = O, H 2 , =NOR or =NNHSO 2 R, where R = H, a straight- or branched-chain 1-4 or 3-4 C alkyl group, R 4 = H, halogen, methyl or trifluoromethyl, R 6 and/or R 7 can be a- or ß-positioned and independently = branched- or straight-chain 1-4 or 3-4 alkyl, or R 6 = H and R 7 = a- or ß-positioned, straight- or branched-chain 1-4 or 3-4 C alkyl, or R 6 and R 7 = H, or R 6 and R 7 together = a- or ß-positioned methylene or an additional bond. The novel compounds have gestagenic and antimineralocorticoid activity and are suitable for the production of pharmaceutical preparations, for example, for oral contraception and the treatment of pre-, peri- and post-menopausal pain.
摘要:
The invention relates to selected anthranylamide pyridones that inhibit VEGFR-2 and VEGFR-3 and to their use as medicaments for treating diseases that are triggered by persistent angiogenesis.
摘要:
The invention relates to 17α-alkyl-17β-oxy-estra-1,3,5(10)-trienes having an anti-oestrogen action, of general formula (I). The invention also relates to 17-oxo-estra-1,3,5(10)-trienes and 17β-hydroxy-estra-1,3,5(10)-trienes as intermediates for producing the inventive estratrienes. The invention further relates to the use of 17α-alkyl-17β-oxy-estratrienes for the production of medicaments and pharmaceutical preparations containing at least one 17α-alkyl-17β-oxy-estratriene and at least one pharmaceutically acceptable carrier.
摘要:
The invention relates to novel 11 beta -halogen-7 alpha -substituted estratrienes of formula (I), wherein R is a fluorine or chlorine atom and the other substituents have the meanings given in the description. The inventive compounds have anti-estrogen or tissue selective estrogenic characteristics and are suitable for producing medicaments.
摘要:
The invention relates to 11β-aryl-substituted 14,17-ethano-oestratriens of general formula (I), in which R1 is a hydrogen atom, a C¿1?-C12-alkanoyl-, a benzoyl-, a straight-chain or branched C1-C12-alkyl-, a C3-C7-cycloalkyl- or a C4-C8-alkyl cycloalkyl group, which can all optionally be substituted; R?2¿ is a hydrogen atom or an optionally substituted C¿1?-C12-alkanoyl group; R?3¿ stands for a group in which n = 4, 5, 6, or 7; m = 0, 1 or 2; R4 or R5 are, independently of each other, a hydrogen atom or a straight-chain or branched, optionally substituted C¿1?-C8-alkyl group, which can also be partially or completely fluorinated, or R?4 and R5¿ together mean a methylene to pentamethylene group -(CH¿2?)p-(p=1-5); and R?6¿ is the same as R4 or R5, or is an optionally substituted aryl or aryl alkyl radical, whereby said alkyl radical can have up to 6 carbon atoms, and the aryl radical, on its own or in the aryl alkyl radical, is a 5 or 6-link monocyclic ring or a condensed 8-10-link ring system, and the aryl radical can have one or more heteroatoms selected from oxygen, nitrogen, and sulphur. The new compounds are selective oestrogens whose effect is tissue-selective. In particular, the oestrogenic effect occurs on bone, in the cardiovascular system and in the central nervous system. However, it has little or no oestrogenic effect on the uterus and the liver. The compounds are suitable for producing medicaments which are used in many indications (for example, for hormone replacement therapy, prevention and treatment of osteoporosis).
摘要:
Described are Ξ-fluorosulphonimides of the general formula (I) (R1-SO2)2NF in which each R1 is a methyl group or the R1 groups together form a -(CH¿2?)n- group in which n=1, 2 or 3, in particular N-fluoromethansulphonimide, (CH3SO2)2NF, their preparation and their use in the electrophilic fluorination of activated C-H bonds in organic molecules.